There are multiple medication classes used for acne. Acne treatment often includes a combination of topical and oral medications. Most medication classes used to treat acne are not an absolute indication to pump and dump. Special considerations are noted below regarding specific medications including isotretinoin (Accutane), Bactrim, and systemic Dapsone.
Commonly used topical products for acne include:
- Retinoids (tretinoin/Retin-A, adapalene, tazarotene, trifarotene)
- Antibiotics (clindamycin, erythromycin, benzoyl peroxide, minocycline, dapsone)
- Comedolytic substances (salicylic acid, azelaic acid)
- Topical androgen inhibitors (clascoterone)
There will likely be minimal amounts that are absorbed and transferred to breast milk with these topical medications. General principles do apply, which include avoiding direct application to the nipple and attempt to avoid direct contact of the infant’s skin with maternal skin that has been treated. If products need to be used on the nipple, an attempt should be made to use water-miscible cream or gel products.
While data is limited on many of these medications and the general principals noted above should be followed, there is no absolute indication to pump and dump with topical medications used for acne. For more information on petroleum-based products, see the section on Petroleum products in Topical Medications (1, 2, 3).
- Isotretinoin (Accutane): No information is known about isotretinoin/Accutane in breastfeeding. However, this medication is known to be highly lipophilic and therefore would likely be found in high concentrations in breastmilk. Therefore, it is best to avoid this medication during lactation and an alternative acne medication should be considered (1).
- Antibiotics (tetracyclines such as doxycycline or minocycline, macrolides, trimethoprim-sulfamethoxazole, cephalosporins, penicillins, dapsone): While infants should be monitored for side effects as noted below, there is no absolute indication to pump and dump with most of the antibiotics used for acne. It is reasonable to monitor the infants of lactating individuals who are taking antibiotics for gastrointestinal side effects such as diarrhea, thrush, diaper rash, or blood in the stool.
- Tetracyclines: These medications generally have a low concentration in the breastmilk and infant absorption is inhibited by the calcium that is contained in the breast milk. There is a theoretical concern for dental enamel staining and bone deposition with longer courses or repeated exposures (1), but there is no absolute indication to pump and dump with short courses (<21 days).
- Trimethoprim-sulfamethoxazole: This medication should be avoided while breastfeeding a G6PD-deficient infant. Otherwise, there is no an absolute indication to pump and dump (1).
- Dapsone: Limited data is available on this medication. It appears to readily enter breast milk. Hemolytic anemia may occur with the use of this medication, especially in newborns (full or preterm) and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Therefore, systemic Dapsone should be used with caution in lactating parents with shared decision making and close monitoring of the infant for signs of hemolytic anemia and an alternative agent should be considered (1).
- Oral Contraceptives: Hormonal contraception during lactation has the risk of decreasing milk production depending on the formulation and when it is administered. While there is a risk to milk production, there is no absolute indication to pump and dump. For more information on contraceptives in the breastfeeding dyad, please see the section on Contraceptives.
- Oral anti androgen (spironolactone): There is no absolute indication to pump and dump (1).
- Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 2014;70:417.e1–10. doi: 10.1016/j.jaad.2013.09.009.
- Noti A, Grob K, Biedermann M et al. Exposure of babies to C(15)-C(45) mineral paraffins from human milk and breast salves. Regul Toxicol Pharmacol. 2003;38:317-25. doi: 10.1016/s0273-2300(03)00098-9.
- National Cancer Institute. Mineral Oils: Untreated and Mildly Treated: https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/mineral-oils (Accessed June 15 2022).
- Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin. 2006;24:167-97. doi: 10.1016/j.det.2006.01.001.
- Zip C. Common sense dermatological drug suggestions for women who are breast-feeding. Skin Therapy Lett. 2002;7:5-7. PMID: 12007012